Ernährung

Präambel

Der Abschnitt „Ernährung” der Leitlinie Colitis ulcerosa” wurde unter Einbeziehung der neueren Literatur aktualisiert. Dabei wurde die 2002 erschienene Leitlinie „Enterale Ernährung” der Deutschen Gesellschaft für Ernährungsmedizin (DGEM) berücksichtigt [1]. Der vorliegende Abschnitt berücksichtigt Besonderheiten bei Kindern, auf die, soweit nötig, in den einzelnen Unterabschnitten gezielt eingegangen wird.

Literatur

• 1 Luebke H, Meier R, Lochs H. et al . DGEM-Leitlinie Enterale Ernährung: Gastroenterologie.  Akt Ernaehr Med. 2003;  69-86 (IV)
• 2 Soncini M, Triossi O, Leo P. et al . Inflammatory bowel disease and hospital treatment in Italy: the RING multi-centre study.  Aliment Pharmacol Ther. 2004;  19 63-68 (IIb)
• 3 Capristo E, Mingrone G, Addolorato G. et al . Metabolic features of inflammatory bowel disease in a remission phase of the disease activity.  J Intern Med. 1998;  243 339-347 (III)
• 4 Jones L A, Harries A D, Rhodes J. et al . Normal energy intake in undernourished patients with Crohn’s disease.  Br Med J (Clin Res Ed). 1984;  288 193 (III)
• 5 Brandes J W, Stenner A, Martini G A. Dietary habits of patients with ulcerative colitis.  Z Gastroenterol. 1997;  17 834-842 (III)
• 6 Tragnone A, Valpiani D, Miglio F. et al . Dietary habits as risk factors for inflammatory bowel disease.  Eur J Gastroenterol Hepatol. 1995;  7 47-51 (III)
• 7 Klein S, Meyers S, O’Sullivan P. The metabolic impact of active ulcerative colitis. Energy expenditure and nitrogen balance.  J Clin Gastroenterol. 1998;  10 34-40 (III)
• 8 Rath H C, Caesar I, Roth M. et al . [Nutritional deficiencies and complications in chronic inflammatory bowel diseases].  Med Klin (Munich). 1998;  93 6-10 (III)
• 9 Franklin J L, Rosenberg H H. Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine).  Gastroenterology. 1973;  64 517-525 (IIb)
• 10 Lashner B A. Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis.  J Cancer Res Clin Oncol. 1993;  119 549-554 (IIb)
• 11 Boot A M, Bouquet J, Krenning E P. et al . Bone mineral density and nutritional status in children with chronic inflammatory bowel disease.  Gut. 1998;  42 188-194 (IIb)
• 12 von Tirpitz C, Steder-Neukamm U, Glas K. et al . Osteoporose bei chronisch entzündlichen Darmerkrankungen - Ergebnisse einer Umfrage an Mitgliedern der Deutschen M. Crohn und Colitis ulcerosa Vereinigung (DCCV).  Z Gastroenterol. 2003;  41 1145-1150 (IIb)
• 13 Godine-Zarfl B, Elmadfa I. Body mass index bei 5 - 18jährigen Kindern und Jugendlichen in Österreich.  Ernährungs-Rundschau. 1994;  41 112 (III)
• 14 Ghosh S, Drummond H E, Ferguson A. Neglect of growth and development in the clinical monitoring of children and teenagers with inflammatory bowel disease: review of case records.  Bmj. 1998;  317 120-121 (III)
• 15 Geerling B J, Badart-Smook A, Stockbrugger R W. et al . Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls.  Eur J Clin Nutr. 2000;  54 514-521 (IIa)
• 16 Fasth S, Hulten L, Magnusson O. et al . The immediate and long-term effects of postoperative total parenteral nutrition on body composition.  Int J Colorectal Dis. 1987;  2 139-145 (IIb)
• 17 Higgens C S, Keighley M R, Allan R N. Impact of preoperative weight loss and body composition changes on postoperative outcome in surgery for inflammatory bowel disease.  Gut. 1984;  25 732-736 (III)
• 18 Lindor K D, Fleming C R, Ilstrup D M. Preoperative nutritional status and other factors that influence surgical outcome in patients with Crohn’s disease.  Mayo Clin Proc. 1985;  60 393-396 (III)
• 19 Fasth S, Hulten L, Magnusson O. et al . Postoperative complications in colorectal surgery in relation to preoperative clinical and nutritional state and postoperative nutritional treatment.  Int J Colorectal Dis. 1987;  2 87-92 (IIa)
• 20 Gasche C, Dejaco C, Waldhoer T. et al . Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial.  Ann Intern Med. 1997;  126 782-787 (Ib)
• 21 Gasche C, Dejaco C, Reinisch W. et al . Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin.  Digestion. 1999;  60 262-267 (III)
• 22 Harries A D, Jones L A, Danis V. et al . Controlled trial of supplemented oral nutrition in Crohn’s disease.  Lancet. 1983;  1 887-890 (IIb)
• 23 Schreiber S, Howaldt S, Schnoor M. et al . Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease.  N Engl J Med. 1996;  334 619-623 (Ib)
• 24 Lashner B A, Provencher K S, Seidner D L. et al . The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis.  Gastroenterology. 1997;  112 29-32 (Ib)
• 25 Dickinson R J, Ashton M G, Axon A T. et al . Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis.  Gastroenterology. 1980;  79 1199-1204 (Ib)
• 26 McIntyre P B, Powell-Tuck J, Wood S R. et al . Controlled trial of bowel rest in the treatment of severe acute colitis.  Gut. 1986;  27 481-485 (Ib)
• 27 Gonzalez-Huix F, Fernandez-Banares F, Esteve-Comas M. et al . Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis.  Am J Gastroenterol. 1993;  88 227-232 (IIb)
• 28 Stenson W F, Cort D, Rodgers J. et al . Dietary supplementation with fish oil in ulcerative colitis.  Ann Intern Med. 1992;  116 609-614 (Ib)
• 29 Loeschke K, Ueberschaer B, Pietsch A. et al . n-3 fatty acids only delay early relapse of ulcerative colitis in remission.  Dig Dis Sci. 1996;  41 2087-2094 (Ib)
• 30 Kanauchi O, Mitsuyama K, Homma T. et al . Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: multi-center open trial.  Int J Mol Med. 2003;  12 701-704 (III)
• 31 Kanauchi O, Suga T, Tochihara M. et al . Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial.  J Gastroenterol. 2002;  37 (Suppl 14) 67-72 (IIa)
• 32 Dichi I, Frenhane P, Dichi J B. et al . Comparison of omega-3 fatty acids and sulfasalazine in ulcerative colitis.  Nutrition. 2000;  16 87-90 (Ib)
• 33 Middleton S J, Naylor S, Woolner J. et al . A double-blind, randomized, placebo-controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis.  Aliment Pharmacol Ther. 2002;  16 1131-1135 (Ib)
• 34 Fernandez-Banares F, Hinojosa J, Sanchez-Lombrana J L. et al . Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn’s Disease and Ulcerative Colitis (GETECCU).  Am J Gastroenterol. 1999;  94 427-433 (Ib)
• 35 Thirlby R C, Kelly R. Pectin and methyl cellulose do not affect intestinal function in patients after ileal pouch-anal anastomosis.  Am J Gastroenterol. 1997;  92 99-102 (IIb)
• 36 Welters C F, Heineman E, Thunnissen F B. et al . Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis.  Dis Colon Rectum. 2002;  45 621-627 (Ib)